EPIDEMIC – A Pfizer-BioNTech study touts the merits of vaccination for 5-11 year olds on Monday
Will children soon be vaccinated against the coronavirus? This possibility was opened on Monday, following the publication of a study by Pfizer-BioNtech laboratories on 4,500 children between 6 months and 11 years old in the United States, Finland, Poland and Spain, including 2,268 aged 5 to 11 years old. The study boasts a vaccine that is “safe” and “well tolerated” by this population, triggering a “robust” immune response despite a lower dosage than the vaccine in the adult population (10 micrograms per injection against 30 micrograms).
For the moment, vaccination is authorized from the age of 12 in France, in the European Union, in the United States and in most countries of the world. Will this study pave the way for vaccination from 5 years old? “20 Minutes” takes stock.
What is the benefit of vaccination for children aged 5 to 11?
Children have very few severe forms of the disease. Of the 8,845 hospitalizations due to Covid-19 in France currently, only 45 concern children between 0 and 9 years old, or 0.5% of the total. The ratio drops further during critical care: 4 children aged 0 to 9 are hospitalized out of a total of 1,805 people, or 0.22%. A possible vaccination of children “will mainly serve to reduce the circulation (…) Read more on 20minutes
Read also :
United States: The Covid-19 has now killed more people than the Spanish flu
Coronavirus: Dominique Simonnot denounces “unworthy” custody conditions during the health crisis
Coronavirus in Yvelines: 99 classes closed in application of school health measures
Coronavirus: A local health pass under consideration by the government, a sensible measure or a risky bet?